Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes

Journal of Controlled Release : Official Journal of the Controlled Release Society
Rita Nieto MontesinosAlf Lamprecht

Abstract

As a result of its broad substrate specificity and critical localization in excretory and barrier function tissues, P-glycoprotein (P-gp) plays major roles in the pharmacokinetics, safety and efficacy profiles of numerous drugs. P-gp is often responsible for the failure of many chemical treatments against cancer, immunosuppressive, infectious and neurodegenerative diseases. Among the therapeutic approaches to circumvent P-gp function, advances in the design of new chemical P-gp modulators to interact specifically with P-gp have yielded few clinical successful reports. Members of a class of components that were initially developed as surface active agents showed promising results with regard to the modulation of P-gp. These components include surfactants and amphiphilic co-polymers. Alternatively, colloidal systems were developed to facilitate drug uptake in resistant cells. This approach is based on the encapsulation of drugs, which masks them from the biological environment and prevents their transport by P-gp using the surfactants released from the nanocarrier. Likewise, a novel and synergistic strategy is currently being explored and involves nanocarrier-mediated transport and controlled release of both P-gp substrates and P...Continue Reading

References

Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P R Twentyman, N M Bleehen
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C Cordon-CardoJ R Bertino
Apr 29, 1988·Biochemical and Biophysical Research Communications·H GoldbergK Skorecki
May 10, 1995·Archives of Biochemistry and Biophysics·P K DudejaJ S Coon
Jul 18, 1997·Science·B AntonssonJ C Martinou
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·V V RaoD Piwnica-Worms
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
Mar 4, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M UhrF Holsboer
Jun 8, 2001·International Journal of Cancer. Journal International Du Cancer·M DemeuleR Béliveau
Sep 5, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·Y LoJ Cherng
Dec 1, 2001·Expert Opinion on Biological Therapy·V AlakhovA Kabanov
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
May 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L van ZuylenJ Verweij
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M F KruijtzerJ H M Schellens
Nov 26, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jason ZastreHelen Burt
Dec 11, 2003·Cancer Chemotherapy and Pharmacology·Liwu FuQichao Pan
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alan SandlerChristopher A Slapak
Sep 24, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joanna M KoziaraRussell J Mumper
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paula M FracassoJan H M Schellens
Nov 30, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Maria Laura ImmordinoLuigi Cattel
Jan 15, 2005·Pharmaceutical Research·Elena V BatrakovaAlexander V Kabanov
Jul 14, 2005·Progress in Neurobiology·Wolfgang Löscher, Heidrun Potschka
Aug 30, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jian-Cheng WangHow-Sung Lee
Dec 15, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Suresh V AmbudkarZuben E Sauna
Dec 29, 2005·FEBS Letters·Richard CallaghanIan D Kerr
Jan 26, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Bradley D AndersonMarkos Leggas
Mar 16, 2006·The Journal of Pharmacology and Experimental Therapeutics·Edna F ChooGrant R Wilkinson
Mar 17, 2006·Biochimica Et Biophysica Acta·Wolfgang E KaminskiJürgen J Wenzel
Apr 1, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alf Lamprecht, Jean-Pierre Benoit

❮ Previous
Next ❯

Citations

Aug 26, 2014·International Journal of Nanomedicine·Jian-Sheng LiuZhen Hong
May 3, 2014·International Journal of Molecular Sciences·Kai ZhangMing Qian Wei
Jun 13, 2015·Drug Development and Industrial Pharmacy·Manu Smriti Singh, Alf Lamprecht
Jan 29, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·A CambónV Mosquera
Dec 26, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ana BeloquiVéronique Préat
May 9, 2014·Bioconjugate Chemistry·Melissa M SprachmanRalph Weissleder
Jun 21, 2014·Molecular Pharmaceutics·Daria Y Alakhova, Alexander V Kabanov
Mar 13, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Gang WangFei Li
Aug 21, 2015·European Journal of Pharmacology·Yawen HuWalter H Hsu
Sep 22, 2015·Molecular Pharmaceutics·Rita Nieto MontesinosYann Pellequer
Dec 2, 2014·International Journal of Pharmaceutics·Manu Smriti Singh, Alf Lamprecht
May 16, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Manu Smriti SinghAlf Lamprecht
Aug 21, 2013·Advanced Drug Delivery Reviews·Yoav D Livney, Yehuda G Assaraf
Jun 9, 2016·Expert Opinion on Drug Metabolism & Toxicology·Mehri NiaziHadi Valizadeh
Apr 15, 2017·Biomacromolecules·Claudia Battistella, Harm-Anton Klok
Sep 1, 2018·Expert Opinion on Drug Delivery·Longfa KouRuijie Chen
Feb 19, 2015·Oncotarget·Xandra García-GonzálezLuis A López-Fernández
May 26, 2018·Nanotechnology·Ivana BoriševAleksandar Djordjevic
Aug 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Juan LuAkira Yamamoto
Aug 14, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Dunja SobotPatrick Couvreur
Dec 24, 2019·Acta Pharmaceutica Sinica. B·Yuhua LiHuichang Bi
Jun 5, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nazneen Pathan, Pravin Shende

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.